Cash & Short-Term Investments

€656.72M

Quarterly · Period ending: Jun 30, 2026 · EUR

Latest reported€656.72M EURperiod endingJun 30, 2026

BMXMF Quarterly Cash & Short-Term Investments · EUR (€20.90M → €656.72M)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

BMXMF cash & short-term investments history

Quarterly · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

bioMérieux S.A. Cash & Short-Term Investments — Quarterly (EUR)
Period ending	Cash & Short-Term Investments (EUR)
Jun 30, 2026	656,715,461
Dec 31, 2025	569,586,587
Jun 30, 2025	380,500,000
Dec 31, 2024	449,800,000
Jun 30, 2024	272,200,000
Dec 31, 2023	352,400,000
Jun 30, 2023	423,000,000
Dec 31, 2022	552,600,000
Jun 30, 2022	524,200,000
Dec 31, 2021	803,500,000
Jun 30, 2021	493,200,000
Dec 31, 2020	389,200,000
Jun 30, 2020	589,500,000
Dec 31, 2019	275,000,000
Jun 30, 2019	247,700,000
Dec 31, 2018	280,100,000
Jun 30, 2018	194,300,000
Dec 31, 2017	312,100,000
Jun 30, 2017	182,200,000
Dec 31, 2016	178,600,000
Jun 30, 2016	126,300,000
Dec 31, 2015	147,100,000
Jun 30, 2015	108,900,000
Dec 31, 2014	119,700,000
Jun 30, 2014	95,100,000
Dec 31, 2013	428,000,000
Jun 30, 2013	58,500,000
Dec 31, 2012	65,600,000
Jun 30, 2012	11,400,000
Dec 31, 2011	42,700,000
Jun 30, 2011	82,400,000
Dec 31, 2010	71,400,000
Jun 30, 2010	33,500,000
Dec 31, 2009	47,000,000
Dec 31, 2008	52,800,000
Dec 31, 2007	54,500,000
Dec 31, 2006	33,900,000
Dec 31, 2005	20,900,000